Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nature Medicine|November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
The Prostate|February 13, 2018
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancerBram De Laere, Steffi Oeyen, Peter Van Oyen, et al.
Genome Medicine|November 22, 2018
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesisMarkus Mayrhofer, Bram De Laere, Tom Whitington, et al.
European Urology|May 16, 2022
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the BladderBernadett Szabados, Mark Kockx, Zoe June Assaf, et al.
NPJ Precision Oncology|March 11, 2025
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancerPieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2018
<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate CancerBram De Laere, Steffi Oeyen, Markus Mayrhofer, et al.
British Journal of Cancer|October 6, 2017
International consensus guidelines for scoring the histopathological growth patterns of liver metastasisPieter-Jan van Dam, Eric P van der Stok, Laure-Anne Teuwen, et al.
Pageof 3